HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

N Hattori Selected Research

Tonic Pupil

12/2000An axonal form of Charcot-Marie-Tooth disease showing distinctive features in association with mutations in the peripheral myelin protein zero gene (Thr124Met or Asp75Val).
2/2000[Two families of Charcot-Marie-Tooth disease with Adie's pupil, axonal neuropahy and the Thr124Met mutation in the peripheral myelin protein zero gene].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


N Hattori Research Topics

Disease

10Parkinson Disease (Parkinson's Disease)
11/2019 - 03/2000
8Parkinsonian Disorders (Parkinsonism)
10/2010 - 01/2000
6Neurodegenerative Diseases (Neurodegenerative Disease)
08/2013 - 03/2000
5Ischemia
03/2015 - 01/2000
5Brain Ischemia (Cerebral Ischemia)
10/2014 - 03/2007
4Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
10/2009 - 02/2001
4Inflammation (Inflammations)
02/2009 - 07/2000
4Alzheimer Disease (Alzheimer's Disease)
12/2002 - 07/2000
3Asthma (Bronchial Asthma)
06/2022 - 06/2008
3Reperfusion Injury
10/2014 - 03/2007
3Infarction (Infarctions)
10/2014 - 07/2001
3Neoplasms (Cancer)
04/2014 - 08/2001
3Polyneuropathies (Polyneuropathy)
10/2009 - 09/2001
3Fibrosis (Cirrhosis)
02/2009 - 02/2000
3Pain (Aches)
08/2007 - 06/2001
3Onychomycosis (Tinea Unguium)
09/2005 - 01/2000
3Charcot-Marie-Tooth Disease (Peroneal Muscular Atrophy)
12/2000 - 02/2000
2Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
10/2014 - 12/2010
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
07/2014 - 12/2001
2Lung Neoplasms (Lung Cancer)
07/2014 - 12/2001
2Stroke (Strokes)
08/2013 - 01/2009
2Brain Injuries (Brain Injury)
12/2010 - 08/2009
2Dystonia (Limb Dystonia)
10/2010 - 09/2000
2Dementia (Dementias)
10/2010 - 09/2000
2Frontotemporal Dementia (Semantic Dementia)
10/2010 - 01/2000
2Eosinophilia
02/2009 - 07/2000
2Pneumonia (Pneumonitis)
01/2009 - 04/2002
2Disease Progression
04/2008 - 06/2001
2Fever (Fevers)
04/2002 - 10/2000
2Cerebrovascular Disorders (Cerebrovascular Occlusion)
04/2002 - 07/2001
2Familial Amyloid Neuropathies (Familial Amyloid Polyneuropathy)
03/2002 - 08/2000
2Peripheral Nervous System Diseases (PNS Diseases)
09/2001 - 01/2001
2Tonic Pupil
12/2000 - 02/2000
2Human Influenza (Influenza)
10/2000 - 01/2000
1Anaphylaxis (Anaphylactic Shock)
06/2022
1Guillain-Barre Syndrome
01/2022
1Myasthenia Gravis
01/2020
1Organizing Pneumonia
05/2019
1Vasculitis (Vasculitides)
08/2018
1Leukemia
01/2016
1Carotid Stenosis (Carotid Artery Stenosis)
03/2015
1Hematologic Neoplasms (Hematological Malignancy)
03/2015
1Ovarian Neoplasms (Ovarian Cancer)
03/2015
1Lymphoma (Lymphomas)
02/2015

Drug/Important Bio-Agent (IBA)

7Proteins (Proteins, Gene)FDA Link
03/2015 - 01/2000
4Pharmaceutical PreparationsIBA
07/2014 - 08/2000
4Levodopa (L Dopa)FDA LinkGeneric
10/2012 - 09/2000
4Intravenous Immunoglobulins (IVIG)FDA Link
10/2009 - 04/2005
3Messenger RNA (mRNA)IBA
01/2022 - 01/2001
3Adrenal Cortex Hormones (Corticosteroids)IBA
05/2019 - 07/2001
3UbiquitinIBA
06/2007 - 12/2000
3alpha-SynucleinIBA
01/2006 - 09/2000
3Myelin P0 Protein (Myelin Protein Zero)IBA
12/2000 - 02/2000
2C-Reactive ProteinIBA
02/2015 - 02/2006
2Lipoproteins (Lipoprotein)IBA
04/2014 - 07/2001
2Cilostazol (Pletal)FDA LinkGeneric
12/2010 - 01/2009
2ElementsIBA
12/2010 - 08/2009
2Carrier Proteins (Binding Protein)IBA
12/2010 - 08/2009
2IronIBA
10/2010 - 10/2001
2prostaglandin R2 D-isomerase (prostaglandin D2 synthase)IBA
09/2009 - 03/2007
2Interleukin-6 (Interleukin 6)IBA
10/2008 - 01/2001
2CytokinesIBA
10/2008 - 01/2001
2SelectinsIBA
04/2008 - 05/2001
2Itraconazole (Sporanox)FDA LinkGeneric
09/2005 - 01/2000
2NucleotidesIBA
11/2002 - 06/2001
2Mitochondrial DNA (mtDNA)IBA
11/2002 - 11/2000
2DNA (Deoxyribonucleic Acid)IBA
11/2002 - 11/2000
2A-factor (Streptomyces)IBA
12/2001 - 02/2001
2Thiamine (Aneurin)FDA Link
09/2001 - 06/2001
2EnzymesIBA
08/2001 - 07/2000
2ImmunosorbentsIBA
08/2001 - 07/2000
2anion-sensitive ATPasesIBA
08/2001 - 04/2001
2stachyflinIBA
10/2000 - 01/2000
2Dihydroxyphenylalanine (Dopa)IBA
09/2000 - 09/2000
1dupilumabIBA
06/2022
1Immunoglobulin G (IgG)IBA
01/2022
1AntibodiesIBA
01/2022
1BNT162 VaccineIBA
01/2022
1COVID-19 VaccinesIBA
01/2022
1Cholinergic ReceptorsIBA
01/2020
1Immunosuppressive Agents (Immunosuppressants)IBA
01/2020
1Tacrolimus (Prograf)FDA LinkGeneric
01/2020
1neuromelaninIBA
11/2019
1Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
08/2018
1Retinoic Acid Receptor alphaIBA
01/2016
1Glutathione S-Transferase piIBA
03/2015
1Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA
03/2015
1Interleukin-2 Receptors (IL 2 Receptor)IBA
02/2015
1Bovine Serum AlbuminIBA
10/2014
1HSP27 Heat-Shock ProteinsIBA
10/2014
1Phosphoric Monoester Hydrolases (Phosphatases)IBA
07/2014
1TensinsIBA
07/2014
1Biological ProductsIBA
07/2014
1selinexorIBA
07/2014
1Glycoproteins (Glycoprotein)IBA
04/2014

Therapy/Procedure

11Therapeutics
05/2019 - 07/2000
2Oral Administration
10/2012 - 11/2009
1Transplantation
02/2015
1Injections
10/2014
1Intravenous Injections
10/2014